The simultaneous patent expiry of Ozempic’s active ingredient in China and India on Friday is a watershed moment. Until now, the revolutionary weight-loss drugs have been available largely to people ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...

DEALING WITH A DIFFICULT SITUATION, OR EVEN JUST BEFORE GOING HOME. A LOW COST ALTERNATIVE FOR COMMONLY USED ASTHMA MEDICATION WILL ENTER THE MARKET AFTER PRESSURE FROM SENATOR MAGGIE HASSAN ...

With 90% of prescriptions in the US filled for generic drugs, there is growing concern that supplies of the medications could be in short supply due to the ongoing situation in the Strait of Hormuz, a ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...

The FDA has approved a generic version of fluticasone propionate (marketed as Flovent HFA), according to a statement issued on March 3. The approval extends the accessibility of the medication, ...

Generic versions of Novo Nordisk A/S’s hit shots Ozempic and Wegovy could be sold for under $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss ...

Codesys's virtualization allows consolidation of plant-floor controllers onto virtual machines, enhancing scalability and operational agility. Cisco’s SDN architecture automates network ...

The generic medication is ⁠expected to be priced 60% lower than Wegovy, per a Reuters report. Wegovy, an under-the-skin injection, is the first approved drug for chronic weight management in adults ...

Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to ...